Los Angeles, CA23 Active Studies

Inflammatory Bowel Disease Clinical Trials in Los Angeles, CA

Find 23 actively recruiting inflammatory bowel disease clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

23
Active Trials
15
Sponsors
8,506
Enrolling

Recruiting Inflammatory Bowel Disease Studies in Los Angeles

About Inflammatory Bowel Disease Clinical Trials in Los Angeles

Inflammatory bowel disease (IBD) encompasses chronic inflammatory conditions of the gastrointestinal tract, primarily Crohn's disease and ulcerative colitis. It affects millions worldwide and can cause debilitating symptoms. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.

There are currently 23 inflammatory bowel disease clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 8,506 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Janssen Research & Development, LLC, Sanofi and 12 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Inflammatory Bowel Disease Clinical Trials in Los Angeles — FAQ

Are there inflammatory bowel disease clinical trials in Los Angeles?

Yes, there are 23 inflammatory bowel disease clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What inflammatory bowel disease treatments are being tested?

The 23 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for inflammatory bowel disease.

Data updated October 17, 2026 from ClinicalTrials.gov